Medtronic Diabetes
Clinical trials sponsored by Medtronic Diabetes, explained in plain language.
-
New 'Artificial Pancreas' system enters human testing
Disease control Not yet recruitingThis study is testing a new, experimental automated insulin delivery system (called the MiniMed NMX8) for people who require insulin for diabetes. It will compare the new system to a currently available one (the MiniMed 780G) to see if it is safe and performs just as well or bett…
Phase: NA • Sponsor: Medtronic Diabetes • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New 'Artificial Pancreas' system aims for better blood sugar control
Disease control Not yet recruitingThis study is testing a new automated insulin delivery system called the NMX8. It aims to see if this new system is as safe and effective as other commercially available systems at helping adults with type 1 diabetes keep their blood sugar in a healthy range. About 230 participan…
Phase: NA • Sponsor: Medtronic Diabetes • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC